4.5 Review

State of the Art of Invasive Group A Streptococcus Infection in Children: A Scoping Review of the Literature with a Focus on Predictors of Invasive Infection

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Increase in invasive group A streptococcal infection notifications, England, 2022

Rebecca Guy et al.

Summary: There has been an increase in invasive group A streptococcal (iGAS) infection and associated deaths, especially in children, exceeding seasonally expected levels in England (772 notifications reported in weeks 37 to 48 in 2022). Diagnoses of iGAS infection from lower respiratory tract specimens in children under 15 years increased to 28% in November 2022. Medical practitioners have been alerted to the exceptional rise in incidence, including unusual numbers of children presenting with pulmonary empyema.

EUROSURVEILLANCE (2023)

Article Immunology

Increase in Invasive Group a Streptococcal Infections in Children in the Netherlands, A Survey Among 7 Hospitals in 2022

Evelien B. van Kempen et al.

Summary: After a rise in notifiable invasive group A streptococcal (iGAS) infections in the Netherlands, a survey was conducted among 7 hospitals. Pediatric iGAS cases were twice as high between July 2021 and June 2022 compared to pre-COVID-19. The surge in early 2022 was most notable in children under 5 and for the diagnoses of empyema and necrotizing fasciitis. Investigation and vigilance are necessary for this recent rise in pediatric iGAS cases.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2023)

Article Immunology

Parental acceptance of and preferences for administration of routine varicella vaccination in the UK: A study to inform policy

Susan M. Sherman et al.

Summary: This study aimed to explore the acceptability and preferences for the introduction of varicella vaccination to the UK childhood immunisation schedule. The results showed that the majority of parents were willing to accept the varicella vaccine for their child, and they preferred it to be administered in combination with the MMR vaccine or on a separate additional visit. These findings provide important insights for vaccine policy, practice, and communication strategy.

VACCINE (2023)

Article Infectious Diseases

Effectiveness of intravenous immunoglobulin therapy for invasive group A Streptococcus infection: A Japanese nationwide observational study

Atsushi Senda et al.

Summary: This study evaluated the effectiveness of intravenous immunoglobulin (IVIG) in the treatment of invasive group A Streptococcus infection (iGAS). The results showed that IVIG treatment had no impact on in-hospital mortality rate and was not associated with 7-day and 30-day mortality rates in iGAS patients.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Immunology

25 Years of Varicella Vaccination in the United States

Mona Marin et al.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

Andrea C. Tricco et al.

ANNALS OF INTERNAL MEDICINE (2018)

Review Microbiology

Group A streptococcal M-like proteins: From pathogenesis to vaccine potential

Hannah R. Frost et al.

FEMS MICROBIOLOGY REVIEWS (2018)

Article Immunology

GROUP A STREPTOCOCCAL BACTEREMIA WITHOUT A SOURCE IS ASSOCIATED WITH LESS SEVERE DISEASE IN CHILDREN

Stefanie Gauguet et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)

Article Pharmacology & Pharmacy

Invasive Group A Streptococcal Disease

Andrew C. Steer et al.

DRUGS (2012)

Article Immunology

CLINICAL AND MICROBIOLOGIC CHARACTERISTICS OF GROUP A STREPTOCOCCAL NECROTIZING FASCIITIS IN CHILDREN

Philippe Minodier et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)

Article Immunology

Risk factors for pediatric invasive group A streptococcal disease

SH Factor et al.

EMERGING INFECTIOUS DISEASES (2005)